Keyphrases
Squamous Cell Carcinoma (SqCC)
100%
Adenocarcinoma
100%
Adenosquamous Carcinoma
100%
Cervical Carcinoma
100%
Survival Rate
72%
Node-positive
63%
Tumor
45%
Surgery Alone
36%
Hysterectomy
27%
Tumor Size
27%
Effects on Survival
27%
American College of Surgeons
18%
Cervical Cancer
18%
Tissue Type
18%
Histologic
18%
Poor Survival
18%
Stage I Disease
18%
Histological Subtypes
18%
Histopathological Features
18%
Stage IB
18%
Clinical Stage I
18%
Nodal Status
18%
Patient Care
9%
Risk Factors
9%
Cancer Stage
9%
Recurrence Rate
9%
Race-ethnicity
9%
Multivariate Analysis
9%
Socioeconomic Background
9%
Treatment Choice
9%
Biologic Activity
9%
Pathological Stage
9%
Commission on Cancer
9%
No Significant Difference
9%
Treatment Type
9%
Combined Treatment
9%
Primary Therapy
9%
Large Series
9%
N-11
9%
Multivariate Regression
9%
Survival Curve
9%
High Survival
9%
Registrar
9%
Independent Prognostic Factor
9%
Combined Surgery
9%
Nodal Metastasis
9%
Anonymous Data
9%
Treatment Other
9%
American Joint Committee on Cancer
9%
Patient Distribution
9%
Medicine and Dentistry
Carcinoma Cell
100%
Adenocarcinoma
100%
Squamous Cell Carcinoma
100%
Cervix
100%
Adenosquamous Carcinoma
90%
Neoplasm
72%
Survival Rate
72%
Clinical Stage
63%
Diseases
36%
Malignant Neoplasm
36%
Hysterectomy
27%
Cervical Cancer
18%
Surgeon
18%
Tissue (Anatomy)
18%
Recurrent Disease
9%
Patient Care
9%
Multivariate Analysis
9%
Stage 2
9%
Evaluation Study
9%
Prognostic Factor
9%
Nodal Metastasis
9%
Nursing and Health Professions
Squamous Cell Carcinoma
100%
Carcinoma
100%
Adenocarcinoma
100%
Adenosquamous Carcinoma
90%
Survival Rate
72%
Neoplasm
45%
Malignant Neoplasm
36%
Disease
36%
Tumor Volume
27%
Hysterectomy
27%
Uterine Cervix Cancer
18%
Surgeon
18%
Evaluation Study
9%
Recurrent Disease
9%
Cancer Staging
9%
Patient Care
9%
Multivariate Analysis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Squamous Cell Carcinoma
100%
Carcinoma
100%
Adenocarcinoma
100%
Adenosquamous Carcinoma
90%
Survival Rate
72%
Neoplasm
72%
Malignant Neoplasm
36%
Disease
36%
Uterine Cervix Cancer
18%
Recurrent Disease
9%
Cancer Staging
9%